Sankey It
Loading...
Eli Lilly and Company FY2024 income statement | Sankey It
Sankey It · LLY
Eli Lilly and Company FY2024 income statement
USD · fiscal year ended 2024-12-31
FY2025
FY2024
FY2023
FY2022
FY2021
Quarterly
Annual
comfortable
compact
Hide amounts
Export
Fullscreen
Eli Lilly and Company FY2024 income statement
Flow diagram with 10 nodes and 9 flows for Eli Lilly and Company FY2024 income statement. Values: Product US$40.7B, Collaboration and Other Revenue US$4.3B, Revenue US$45B, Cost of Revenue US$8.4B, Gross Profit US$36.6B, Operating Expenses US$19.1B, Operating Income US$17.5B, Other Expense US$4.8B, Tax US$2.1B, Net Income US$10.6B.
Product
US$40.7B
+41% Y/Y
90% of revenue
Collaboration and Other Revenue
US$4.3B
-19% Y/Y
10% of revenue
Revenue
US$45B
+32% Y/Y
Cost of Revenue
(US$8.4B)
+19% Y/Y
19% of revenue
Gross Profit
US$36.6B
+35% Y/Y
81% margin
Operating Expenses
(US$19.1B)
+18% Y/Y
42% of revenue
Operating Income
US$17.5B
+62% Y/Y
39% margin
Other Expense
(US$4.8B)
+14% Y/Y
11% of revenue
Tax
(US$2.1B)
+59% Y/Y
5% of revenue
Net Income
US$10.6B
+102% Y/Y
24% margin
Net / profit
Inputs
Tax / cost
Copy link
Share on X
Open full screen